These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28900480)

  • 1. HPV test results and histological follow-up results of patients with LSIL Cervical Cytology from the Largest CAP-certified laboratory in China.
    Zheng B; Yang H; Li Z; Wei G; You J; Liang X; Zhao C
    J Cancer; 2017; 8(13):2436-2441. PubMed ID: 28900480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up with histopathology and HPV testing on LSIL cytology in China's largest academic woman's hospital.
    Tao X; Zhang H; Zhang H; Xiao J; Li J; Zhou X; Wang L; Zhao C
    Cancer Cytopathol; 2019 Apr; 127(4):258-266. PubMed ID: 30892831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate histopathologic follow-up of cervista and aptima high-risk HPV assays in women with LSIL cytology.
    Zhang H; Varma KR; Han M; Matsko J; Zhao C
    Cancer Cytopathol; 2018 Aug; 126(8):525-532. PubMed ID: 29797678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical Squamous Cells of Undetermined Significance Cervical Cytology Report Rate and Histologic Follow-up Findings From the Largest College of American Pathologists-Certified Laboratory in China.
    Zheng B; Yang H; Li Z; You J; Wei G; Zhang H; Zeng Z; Xie F; Zhao C
    Arch Pathol Lab Med; 2019 Jun; 143(6):748-752. PubMed ID: 30605022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV test results stratify risk for histopathologic follow-up findings of high-grade cervical intra-epithelial neoplasia in women with low-grade squamous intra-epithelial lesion Pap results.
    Heider A; Austin RM; Zhao C
    Acta Cytol; 2011; 55(1):48-53. PubMed ID: 21135522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-up outcomes for a large cohort of US women with negative imaged liquid-based cytology findings and positive high risk human papillomavirus test results.
    Zhao C; Chen X; Onisko A; Kanbour A; Austin RM
    Gynecol Oncol; 2011 Aug; 122(2):291-6. PubMed ID: 21601911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
    Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPV of an HSIL cervical cytology result in China's largest CAP-certified laboratory.
    Zheng B; Austin RM; Liang X; Li Z; Chen C; Yan S; Zhao C
    J Am Soc Cytopathol; 2015; 4(2):84-89. PubMed ID: 31051714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV detection rates and histopathologic follow-up of patients with HSIL cytology in a large academic women's hospital laboratory.
    Ashman D; Zhang H; Li J; Austin M; Wang T; Pradhan D; Zhao C
    J Am Soc Cytopathol; 2020; 9(6):550-555. PubMed ID: 32475726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Previous Papanicolaou and Hybrid Capture 2 human papillomavirus testing results of 5699 women with histologically diagnosed cervical intraepithelial neoplasia 2/3.
    Wu T; Chen X; Zheng B; Li J; Xie F; Ding X; Zeng Z; Zhao C
    J Am Soc Cytopathol; 2019; 8(4):206-211. PubMed ID: 31272603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
    Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical Cytology Reporting Rates from China's Largest College of American Pathologists-Certified Laboratory with a Focus on Squamous Cell Carcinoma Cytology and Its Histopathological Follow-Up Results.
    Zheng B; Li Z; Liang X; Austin RM; Chen C; Zhao C
    Acta Cytol; 2015; 59(5):399-404. PubMed ID: 26655168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
    Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-grade squamous intraepithelial lesion/cannot exclude high-grade squamous intraepithelial lesion (LSIL-H) is a unique category of cytologic abnormality associated with distinctive HPV and histopathologic CIN 2+ detection rates.
    Barron S; Li Z; Austin RM; Zhao C
    Am J Clin Pathol; 2014 Feb; 141(2):239-46. PubMed ID: 24436272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytology versus HPV testing for cervical cancer screening in the general population.
    Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical performance of the aptima HPV assay in 4196 women with positive high-risk HPV and ASC-US cytology: A large women hospital experience.
    Wang T; Pradhan D; Zhang H; Matsko J; Zhao C
    Diagn Cytopathol; 2021 Jan; 49(1):5-10. PubMed ID: 32857920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
    Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year risks of CIN 2+ and CIN 3+ among women with HPV-positive and HPV-negative LSIL Pap results.
    Katki HA; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Gage JC; Kinney WK
    J Low Genit Tract Dis; 2013 Apr; 17(5 Suppl 1):S43-9. PubMed ID: 23519304
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.